MRC1 and neoplasm: In this short-term phagocytosis assay, we assessed: (1) MDM polarization, by human CD163, CD206, HLA-DR, and CD86; (2) phagocytic marker expression, by human CD209; (3) antigen presentation, by human SIGLEC-1, and (4) tumor cell phagocytosis.